Saltar al contenido principal

22-431 Offer Patients Added Treatment Options for COVID-19 with Oral Antivirals

June 10, 2022

This information applies to Physicians and Independent Practice Associations.

PaxlovidTM and LagevrioTM – authorized for emergency use by the U.S. Food and Drug Administration – can be prescribed to treat mild to moderate COVID-19 for use at home.

This flyer shares information about two COVID-19 oral antiviral medications – PaxlovidTM and LagevrioTM. These are available by prescription only to individuals who qualify, have mild to moderate COVID-19 symptoms and who are at high risk.

Download the provider updateEste documento PDF se abrirá en una ventana nueva.

Ícono de contacto

¿Necesita ayuda? Puede contar con nosotros.

Contáctenos
Y0020_WCM_87476E Last Updated On: 2/9/2024